|
1
|
Choubey D and Panchanathan R: IFI16, an
amplifier of DNA-damage response: Role in cellular senescence and
aging-associated inflammatory diseases. Ageing Res Rev. 28:27–36.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ouchi M and Ouchi T: Role of IFI16 in DNA
damage and checkpoint. Front Biosci. 13:236–239. 2008. View Article : Google Scholar
|
|
3
|
Duan X, Ponomareva L, Veeranki S,
Panchanathan R, Dickerson E and Choubey D: Differential roles for
the interferon-inducible IFI16 and AIM2 innate immune sensors for
cytosolic DNA in cellular senescence of human fibroblasts. Mol
Cancer Res. 9:589–602. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stratmann SA, Morrone SR, van Oijen AM and
Sohn J: The innate immune sensor IFI16 recognizes foreign DNA in
the nucleus by scanning along the duplex. ELife. 4:e117212015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Unterholzner L, Keating SE, Baran M, Horan
KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, et al:
IFI16 is an innate immune sensor for intracellular DNA. Nat
Immunol. 11:997–1004. 2010. View
Article : Google Scholar
|
|
6
|
Orzalli MH, DeLuca NA and Knipe DM:
Nuclear IFI16 induction of IRF-3 signaling during herpesviral
infection and degradation of IFI16 by the viral ICP0 protein. Proc
Natl Acad Sci USA. 109:E3008–E3017. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choubey D, Deka R and Ho SM:
Interferon-inducible IFI16 protein in human cancers and autoimmune
diseases. Front Biosci. 13:598–608. 2008. View Article : Google Scholar
|
|
8
|
Johnstone RW and Trapani JA: Transcription
and growth regulatory functions of the HIN-200 family of proteins.
Mol Cell Biol. 19:5833–5838. 1999. View Article : Google Scholar
|
|
9
|
Ludlow LE, Johnstone RW and Clarke CJ: The
HIN-200 family: More than interferon-inducible genes? Exp Cell Res.
308:1–17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choubey D, Duan X, Dickerson E, Ponomareva
L, Panchanathan R, Shen H and Srivastava R: Interferon-inducible
p200-family proteins as novel sensors of cytoplasmic DNA: Role in
inflammation and autoimmunity. J Interferon Cytokine Res.
30:371–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Veeranki S and Choubey D:
Interferon-inducible p200-family protein IFI16, an innate immune
sensor for cytosolic and nuclear double-stranded DNA: Regulation of
subcellular localization. Mol Immunol. 49:567–571. 2012. View Article : Google Scholar
|
|
12
|
Decout A, Katz JD, Venkatraman S and
Ablasser A: The cGAS-STING pathway as a therapeutic target in
inflammatory diseases. Nat Rev Immunol. 21:548–569. 2021.
View Article : Google Scholar
|
|
13
|
Bhat N and Fitzgerald KA: Recognition of
cytosolic DNA by cGAS and other STING-dependent sensors. Eur J
Immunol. 44:634–640. 2014. View Article : Google Scholar
|
|
14
|
Thompson MR, Sharma S, Atianand M, Jensen
SB, Carpenter S, Knipe DM, Fitzgerald KA and Kurt-Jones EA:
Interferon γ-inducible Protein (IFI) 16 transcriptionally regulates
Type I interferons and other interferon-stimulated genes and
controls the interferon response to both DNA and RNA viruses. J
Biol Chem. 289:235682014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kopitar-Jerala N: The role of interferons
in inflammation and inflammasome activation. Front Immunol.
8:8732017. View Article : Google Scholar
|
|
16
|
Itsui Y, Sakamoto N, Kurosaki M, Kanazawa
N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S and Sekine
Y: Expressional screening of interferon-stimulated genes for
antiviral activity against hepatitis C virus replication. J Viral
Hepat. 13:690–700. 2006. View Article : Google Scholar
|
|
17
|
Jiang D, Guo H, Xu C, Chang J, Gu B, Wang
L, Block TM and Guo JT: Identification of three
interferon-inducible cellular enzymes that inhibit the replication
of hepatitis C virus. J Virol. 82:1665–1678. 2008. View Article : Google Scholar
|
|
18
|
Schoggins JW and Rice CM:
Interferon-stimulated genes and their antiviral effector functions.
Curr Opin Virol. 1:5192011. View Article : Google Scholar
|
|
19
|
Xin H, Curry J, Johnstone RW, Nickoloff BJ
and Choubey D: Role of IFI 16, a member of the interferon-inducible
p200-protein family, in prostate epithelial cellular senescence.
Oncogene. 22:4831–4840. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duan X, Ponomareva L, Veeranki S and
Choubey D: IFI16 induction by glucose restriction in human
fibroblasts contributes to autophagy through activation of the
ATM/AMPK/p53 pathway. PLoS One. 6:e1953220122 View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin W, Zhao Z, Ni Z, Zhao Y, Du W and Chen
S: IFI16 restoration in hepatocellular carcinoma induces tumour
inhibition via activation of p53 signals and inflammasome. Cell
Prolif. 50:e123922017. View Article : Google Scholar
|
|
22
|
Kondo Y, Nagai K, Nakahata S, Saito Y,
Ichikawa T, Suekane A, Taki T, Iwakawa R, Enari M, Taniwaki M, et
al: Overexpression of the DNA sensor proteins, absent in melanoma 2
and interferon-inducible 16, contributes to tumorigenesis of oral
squamous cell carcinoma with p53 inactivation. Cancer Sci.
103:782–790. 2012. View Article : Google Scholar
|
|
23
|
Yu B, Zheng X, Sun Z, Cao P, Zhang J and
Wang W: IFI16 can be used as a biomarker for diagnosis of renal
cell carcinoma and prediction of patient survival. Front Genet.
12:5999522012. View Article : Google Scholar
|
|
24
|
Chen JX, Cheng CS, Gao HF, Chen ZJ, Lv LL,
Xu JY, Shen XH, Xie J and Zheng L: Overexpression of
interferon-inducible Protein 16 promotes progression of human
pancreatic adenocarcinoma through interleukin-1β-induced
tumor-associated macrophage infiltration in the tumor
microenvironment. Front Cell Dev Biol. 9:6407862021. View Article : Google Scholar
|
|
25
|
Intra J and Kuo SM: Physiological levels
of tea catechins increase cellular lipid antioxidant activity of
vitamin C and vitamin E in human intestinal Caco-2 cells. Chem Biol
Interact. 169:91–99. 2007. View Article : Google Scholar
|
|
26
|
Cione E, La Torre C, Cannataro R, Caroleo
MC, Plastina P and Gallelli L: Quercetin, epigallocatechin gallate,
curcumin, and resveratrol: From dietary sources to human MicroRNA
modulation. Molecules. 25:632019. View Article : Google Scholar
|
|
27
|
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H,
Welsh W and Yang CS: Tea polyphenol (−)-epigallocatechin-3-gallate
inhibits DNA methyltransferase and reactivates methylation-silenced
genes in cancer cell lines. Cancer Res. 63:7563–7570.
2003.PubMed/NCBI
|
|
28
|
Beetch M, Harandi-Zadeh S, Shen K, Lubecka
K, Kitts DD, O'Hagan HM and Stefanska B: Dietary antioxidants
remodel DNA methylation patterns in chronic disease. Br J
Pharmacol. 177:1382–1408. 2020. View Article : Google Scholar
|
|
29
|
Kuo CL, Chen TS, Liou SY and Hsieh CC:
Immunomodulatory effects of EGCG fraction of green tea extract in
innate and adaptive immunity via T regulatory cells in murine
model. Immunopharmacol Immunotoxicol. 36:364–370. 2014. View Article : Google Scholar
|
|
30
|
Nance Cl, Mata M, McMullen A, McMullen A
and Shearer WT: Regulation of innate immune recognition of viral
infection by epigallocatechin gallate. J Allergy Clin Immunol.
133:AB2462014. View Article : Google Scholar
|
|
31
|
Liu M, Ohtani H, Zhou W, Ørskov AD,
Charlet J, Zhang YW, Shen H, Baylin SB, Liang G, Grønbæk K and
Jones PA: Vitamin C increases viral mimicry induced by
5-aza-2′-deoxycytidine. Proc Natl Acad Sci USA. 113:10238–10244.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li T, Diner BA, Chen J and Cristea IM:
Acetylation modulates cellular distribution and DNA sensing ability
of interferon-inducible protein IFI16. Proc Natl Acad Sci.
109:10558–10563. 2012. View Article : Google Scholar
|
|
33
|
Alimirah F, Chen J, Davis FJ and Choubey
D: IFI16 in human prostate cancer. Mol Cancer Res. 5:251–259. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takeshima H, Yoda Y, Wakabayashi M,
Hattori N, Yamashita S and Ushijima T: Low-dose DNA demethylating
therapy induces reprogramming of diverse cancer-related pathways at
the single-cell level. Clin Epigenetics. 12:1422020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morris J, Moseley VR, Cabang AB, Coleman
K, Wei W, Garrett-Mayer E and Wargovich MJ: Reduction in promotor
methylation utilizing EGCG (epigallocatechin-3-gallate) restores
RXRα expression in human colon cancer cells. Oncotarget.
7:35313–35326. 2016. View Article : Google Scholar
|
|
36
|
Huang CY, Han Z, Li X, Xie HH and Zhu SS:
Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human
breast cancer. Oncol Lett. 14:3623–3627. 2017. View Article : Google Scholar
|
|
37
|
Moradzadeh M, Hosseini A, Erfanian S and
Rezaei H: Epigallocatechin-3-gallate promotes apoptosis in human
breast cancer T47D cells through down-regulation of PI3K/AKT and
Telomerase. Pharmacol Rep. 69:924–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roulois D, Loo Yau H, Singhania R, Wang Y,
Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, et al:
DNA-demethylating agents target colorectal cancer cells by inducing
viral mimicry by endogenous transcripts. Cell. 162:961–973. 2015.
View Article : Google Scholar
|
|
39
|
Rialdi A, Campisi L, Zhao N, Lagda AC,
Pietzsch C, Ho JSY, Martinez-Gil L, Fenouil R, Chen X, Edwards M,
et al: Topoisomerase 1 inhibition suppresses inflammatory genes and
protects from death by inflammation. Science. 352:aad79932016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Islam MR, Awal MA, Khames A, Abourehab
MAS, Samad A, Hassan WMI, Alam R, Osman OI, Nur SM, Molla MHR, et
al: Computational identification of druggable bioactive compounds
from catharanthus roseus and avicennia marina against colorectal
cancer by targeting thymidylate synthase. Mol. 27:20892022.
View Article : Google Scholar
|
|
42
|
Ikwu FA, Shallangwa GA, Mamza PA and
Uzairu A: In silico studies of piperazine derivatives as potent
anti-proliferative agents against PC-3 prostate cancer cell lines.
Heliyon. 6:e032732020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zevini A, Olagnier D and Hiscott J:
Crosstalk between cytoplasmic RIG-I and STING sensing pathways.
Trends Immunol. 38:194–205. 2017. View Article : Google Scholar
|
|
44
|
Nur SM, Rath S, Ahmad V, Ahmad A, Ateeq B
and Khan MI: Nutritive vitamins as epidrugs. Crit Rev Food Sci
Nutr. 61:1–13. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
de Ruyck J, Brysbaert G, Blossey R and
Lensink MF: Molecular docking as a popular tool in drug design, an
in silico travel. Adv Appl Bioinform Chem. 9:1–11. 2016.PubMed/NCBI
|
|
46
|
Won JL, Shim JY and Zhu BT: Mechanisms for
the inhibition of DNA methyltransferases by tea catechins and
bioflavonoids. Mol Pharmacol. 68:1018–1030. 2005. View Article : Google Scholar
|
|
47
|
Okude H, Ori D and Kawai T: Signaling
through nucleic acid sensors and their roles in inflammatory
diseases. Front Immunol. 11:6258332021. View Article : Google Scholar
|
|
48
|
Chiappinelli KB, Strissel PL, Desrichard
A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, et
al: Erratum: Inhibiting DNA methylation causes an interferon
response in cancer via dsRNA including endogenous retroviruses.
Cell. 152:974–986. 2015. View Article : Google Scholar
|
|
49
|
Sheng J, Shi W, Guo H, Long W, Wang Y, Qi
J, Liu J and Xu Y: The inhibitory effect of
(−)-Epigallocatechin-3-Gallate on breast cancer progression via
reducing SCUBE2 methylation and DNMT activity. Molecules.
24:28992019. View Article : Google Scholar
|
|
50
|
Nandakumar V, Vaid M and Katiyar SK:
(−)-Epigallocatechin-3-gallate reactivates silenced tumor
suppressor genes, Cip1/p21 and p 16 INK4a, by reducing DNA
methylation and increasing histones acetylation in human skin
cancer cells. Carcinogenesis. 32:537–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Blaschke K, Ebata KT, Karimi MM,
Zepeda-Martínez JA, Goyal P, Mahapatra S, Tam A, Laird DJ, Hirst M,
Rao A, et al: Vitamin C induces Tet-dependent DNA demethylation and
a blastocyst-like state in ES cells. Nature. 500:222–226. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rajavelu A, Lungu C, Emperle M, Dukatz M,
Bröhm A, Broche J, Hanelt I, Parsa E, Schiffers S, Karnik R, et al:
Chromatin-dependent allosteric regulation of DNMT3A activity by
MeCP2. Nucleic Acids Res. 46:9044–9056. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bostick M, Jong KK, Estève PO, Clark A,
Pradhan S and Jacobsen SE: UHRF1 plays a role in maintaining DNA
methylation in mammalian cells. Science. 317:1760–1764. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Khan MA, Hussain A, Sundaram MK, Alalami
U, Gunasekera D, Ramesh L, Hamza A and Quraishi U:
(−)-Epigallocatechin-3-gallate reverses the expression of various
tumor-suppressor genes by inhibiting DNA methyltransferases and
histone deacetylases in human cervical cancer cells. Oncol Rep.
33:1976–1984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yiannakopoulou EC: Targeting DNA
methylation with green tea catechins. Pharmacology. 95:111–116.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Alivand MR, Najafi S, Esmaeili S,
Rahmanpour D, Zhaleh H and Rahmati Y: Integrative analysis of DNA
methylation and gene expression profiles to identify biomarkers of
glioblastoma. Cancer Genet. 258–259. 135–150. 2021.
|
